...
首页> 外文期刊>Pharmaceutical Biology >Sika pilose antler type I collagen promotes BMSC differentiation via the ERK1/2 and p38-MAPK signal pathways
【24h】

Sika pilose antler type I collagen promotes BMSC differentiation via the ERK1/2 and p38-MAPK signal pathways

机译:梅花鹿茸I型胶原通过ERK1 / 2和p38-MAPK信号通路促进BMSC分化

获取原文

摘要

Sika pilose antler type I collagen (SPC-I) have been reported to promote bone marrow mesenchymal stem cell (BMSC) proliferation and differentiation. However, the underlying mechanism is still unclear. This study investigates the molecular mechanisms of SPC-I on the BMSC proliferation and differentiation of osteoblast (OB) in vitro. The primary rat BMSC was cultured and exposed to SPC-I at different concentrations (2.5, 5.0 and 10.0?mg/mL) for 20?days. The effect of SPC-I on the differentiation of BMSCs was evaluated through detecting the activity of alkaline phosphatase (ALP), ALP staining, collagen I (Col-I) content, and calcified nodules. The markers of osteoblastic differentiation were evaluated using RT-PCR and Western-blot analysis. SPC-I treatment (2.5?mg/mL) significantly increased the proliferation of BMSCs (p??0.01), whereas, SPC-I (5.0 and 10.0?mg/mL) significantly inhibited the proliferation of BMSCs (p??0.01). SPC-I (2.5?mg/mL) significantly increased ALP activity and Col-I content (p??0.01), and increased positive cells in ALP staining and the formation of calcified nodules. Additionally, the gene expression of ALP, Col-I, Osteocalcin (OC), Runx2, Osterix (Osx), ERK1/2, BMP2 and p38-MAPK, along with the protein expression of ERK1/2, p-ERK1/2, p-p38 MAPK were markedly increased in the SPC-I (5.0?mg/mL) treatment group (p??0.01) compared to the control group. SPC-I can induce BMSC differentiation into OBs and enhance the function of osteogenesis through ERK1/2 and p38-MAPK signal transduction pathways and regulating the gene expression of osteogenesis-specific transcription factors.
机译:据报道,Sika鹿茸I型胶原蛋白(SPC-1)可以促进骨髓间充质干细胞(BMSC)增殖和分化。但是,其潜在机制仍不清楚。本研究探讨了SPC-1对体外成骨细胞(OB)BMSC增殖和分化的分子机制。培养原代大鼠BMSC,并以不同浓度(2.5、5.0和10.0?mg / mL)的SPC-1暴露20天。通过检测碱性磷酸酶(ALP)的活性,ALP染色,胶原I(Col-1)含量和钙化结节,评估了SPC-1对BMSCs分化的影响。使用RT-PCR和Western-blot分析评估成骨细胞分化的标志物。 SPC-1处理(2.5?mg / mL)显着增加了BMSCs的增殖(p 0.01),而SPC-1(5.0和10.0?mg / mL)显着抑制了BMSCs的增殖(p 0.01)。 0.01)。 SPC-I(2.5?mg / mL)显着增加了ALP活性和Col-I含量(p 0.01),并增加了ALP染色中阳性细胞的数量和钙化结节的形成。此外,ALP,Col-I,骨钙蛋白(OC),Runx2,Osterix(Osx),ERK1 / 2,BMP2和p38-MAPK的基因表达,以及ERK1 / 2,p-ERK1 / 2,与对照组相比,SPC-1(5.0?mg / mL)治疗组中p-p38 MAPK显着增加(p 0.01)。 SPC-1可通过ERK1 / 2和p38-MAPK信号转导途径诱导BMSC分化为OB,增强成骨功能,并调节成骨特异性转录因子的基因表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号